Skip to main content

HealthTimes

Global Health

A New Virus ‘Nipah,’ Deadlier Than COVID-19 Emerges In India, Kills Boy 12

Michael Gwarisa

A 12-year-old boy has died in India of Nipah, a rare virus that is far deadlier than COVID-19 — and one that health officials have long feared could start a global pandemic. The unidentified boy died Sunday at a hospital in Kerala, the southern state already battling the highest number of COVID-19 cases in the

Read More
Global Health

Here’s What We Know About C.1.2.—South Africa’s New, Highly Mutated Covid Variant

Michael Gwarisa

SOURCE: FORBES Topline There has been a lot of buzz this past week over a new coronavirus variant identified in South Africa that appears to be more highly mutated than any other variant flagged by the World Health Organization (WHO) as a variant of interest or concern, but still comprises just a small share of

Read More
Global Health

WHO Mulls Digital Documentation of COVID-19 Vaccination Certificates

Michael Gwarisa

THE World Health Organisation (WHO) has published a guidance document for countries and implementing partners on the technical requirements for issuing digital certificates for vaccination against COVDI-19. By Michael Gwarisa Through their official international Website, WHO said the Digital Documentation of COVID-19 Certificates is being proposed as a mechanism by which a person’s COVID-19-related health

Read More
Global Health Health News

CDC Warns That Delta Variant Now Infecting Vaccinated People, The Variant Is More Contagious Than Chicken Pox

Michael Gwarisa

THE Centers for Disease Control and Prevention has issued a stern warning about the delta variant of the coronavirus: “Acknowledge the war has changed.” Now, it says even vaccinated people are able to readily spread the virus. That is part of the message from a recent internal presentation prepared by the CDC detailing findings, some

Read More
diabates 1
Global Health Health News

Major Diabetes Breakthrough On The Horizon As Once In A Week Insulin Drug Is Under Development

Michael Gwarisa

A new weekly insulin shot that lasts for 196 hours is currently under development in a move that bis likely to improve health outcomes for people living diabetes. Article Originally Published By Medical Health Today The new modified version of insulin is called Insulin icodec and has undergone two trials and according to experts, the

Read More
117500069 9db48266 1bb0 40c4 9c75 b6d2b06c30be
Global Health

India Discovers New COVID-19 Mutant Strain Resistant To Natural And Vaccine Acquired Immunity

Michael Gwarisa

SOURCE: BBC A new “double mutant” variant of the coronavirus has been detected from samples collected in India. Officials are checking if the variant, where two mutations come together in the same virus, may be more infectious or less affected by vaccines. Some 10,787 samples from 18 Indian states also showed up 771 cases of

Read More
Global Health

Ageism is a global challenge: UN

Michael Gwarisa

A new report on Ageism that has been released by the United Nations (UN) indicates that every second person in the world is believed to hold ageist attitudes – leading to poorer physical and mental health and reduced quality of life for older persons, costing societies billions of dollars each year. Staff Reporter The report

Read More
WHO TB Zambia GarethBentley 157
Global Health

1 in 4 people projected to have hearing problems by 2050

Michael Gwarisa

Nearly 2.5 billion people worldwide ─ or 1 in 4 people ─ will be living with some degree of hearing loss by 2050, warns the World Health Organization’s (WHO) first World Report on Hearing, released today. At least 700 million of these people will require access to ear and hearing care and other rehabilitation services

Read More
UN070241
Global Health

Compensation For COVAX Vaccine Recipients Who Develop Serious Reactions

Michael Gwarisa

THE World Health Organisation (WHO) has signed a no -fault compensation deal which will see  a lump-sum payment being made to recipients of the the COVAX vaccine who would have developed serious side effects and reaction getting paid for damages that would have occurred. By Michael Gwarisa The World Health Organization (WHO) and Chubb Limited

Read More
jonson
Global Health

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial

Michael Gwarisa

Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468

Read More